GST NO. : 27AEZFS4094K1ZY
| Business Type | Exporter, Supplier, Trader |
| Packaging Type | Box |
| Strength | 4mg |
| Indicated For | Osteoporosis, Paget's Disease, Bone Metastases |
| Click to view more | |
Product Details
Active Ingredient
Zoledronic Acid
Dosage Form
Intravenous (IV) Injection
Benefits
Reduces Fracture Risks And Bone Loss
Administration
Given By A Healthcare Professional
Monitoring Required
Kidney Function And Calcium Levels
Product Description
- Indicated For: Osteoporosis, Paget’s disease, bone metastases
- Active Ingredient: Zoledronic Acid 4mg
- Mechanism of Action: Inhibits bone resorption and strengthens bones
- Dosage Form: Intravenous (IV) injection
- Benefits: Reduces fracture risks and bone loss
- Administration: Given by a healthcare professional
- Monitoring Required: Kidney function and calcium levels
- Zoldria 4mg contains Zoledronic Acid (4mg), a bisphosphonate used to treat osteoporosis, Paget’s disease, and bone complications caused by cancer. It works by inhibiting bone breakdown, increasing bone density, and reducing fracture risks. This intravenous injection is commonly prescribed for postmenopausal women, individuals with osteoporosis, and cancer patients with bone metastases. Zoldria 4mg is administered under medical supervision, typically once a year or as recommended by a physician. Regular monitoring of kidney function and calcium levels is necessary to prevent complications. It is a trusted solution for managing bone health and preventing fractures in high-risk patients.a
Looking for "Zoldria Zoledronic Acid Injection" ?
Box
